Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Tables)

v3.21.2
Significant Accounting Policies (Tables)
9 Months Ended
Oct. 31, 2021
Accounting Policies [Abstract]  
Summary of Cash, Cash Equivalents, and Restricted Cash

The following table provides a summary of (i) cash and cash equivalents and (ii) restricted cash in the consolidated statements of cash flows as of the periods presented:

 

 

 

As of October 31,

 

 

 

2021

 

 

2020

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

17,551

 

 

$

4,904

 

Restricted cash

 

 

339

 

 

 

220

 

Total cash, cash equivalents and restricted cash

 

$

17,890

 

 

$

5,124

 

 

 

 

As of January 31,

 

 

 

2021

 

 

2020

 

 

 

(Amounts in thousands)

 

Cash and cash equivalents

 

$

5,856

 

 

$

9,013

 

Restricted cash

 

 

228

 

 

 

284

 

Total cash, cash equivalents and restricted cash

 

$

6,084

 

 

$

9,297

 

Schedule of Anti-dilutive Securities Excluded from Computation of Loss Per Share

The number of common shares used in the computation of diluted net loss per share for the periods presented does not include the effect of the following potentially outstanding common shares because the effect would have been anti-dilutive:

 

 

 

For the Three Months

Ended October 31,

 

 

For the Nine Months

Ended October 31,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

 

 

(Amounts in thousands)

 

 

(Amounts in thousands)

 

Stock options

 

 

1,287

 

 

 

2,643

 

 

 

1,542

 

 

 

1,072

 

Restricted stock units

 

 

273

 

 

 

341

 

 

 

120

 

 

 

58

 

Deferred stock units

 

 

62

 

 

 

313

 

 

 

41

 

 

 

82

 

 

 

 

1,622

 

 

 

3,297

 

 

 

1,703

 

 

 

1,212